Literature DB >> 15239104

Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals.

Makoto Asamoto1, Naomi Hokaiwado, Toshiya Murasaki, Tomoyuki Shirai.   

Abstract

Connexins are subunits of gap junction channels, which allow direct transfer of ions, secondary messenger molecules, and other metabolites between contacting cells. Gap junctions are believed to be involved in tissue homeostasis, embryonic development, and control of cell proliferation. Several studies have shown that cell damage signals are transmitted through gap junctions when cells are irradiated or when cells bearing the herpes simplex virus-thymidine kinase (HSV-TK) gene are treated with ganciclovir. We established 2 lines of transgenic rats with a dominant-negative mutant of connexin 32 gene under control of the albumin promoter. In the livers of transgenic rats, membrane localization of normal endogenous connexin 32 protein is disturbed, and gap junction capacity measured by scrape dye-transfer assay in vivo is markedly decreased when compared with wild-type rats. The present investigation concerned susceptibility to the liver-toxic substances D-galactosamine and carbon tetrachloride. These toxicants induced massive liver cell death and elevated serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in the wild-type rats; however, much fewer liver cells were damaged and serum enzyme elevation was much lower in the transgenic rats. In conclusion, gap junctional intercellular communication (GJIC) plays an important role in toxic effects of chemicals; damage or death signals may pass through gap junctions in the rat liver in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239104     DOI: 10.1002/hep.20256

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

1.  Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization.

Authors:  Woo-Jae Park; Joo-Won Park; Racheli Erez-Roman; Aviram Kogot-Levin; Jessica R Bame; Boaz Tirosh; Ann Saada; Alfred H Merrill; Yael Pewzner-Jung; Anthony H Futerman
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

2.  The gap junction as a "Biological Rosetta Stone": implications of evolution, stem cells to homeostatic regulation of health and disease in the Barker hypothesis.

Authors:  James E Trosko
Journal:  J Cell Commun Signal       Date:  2010-12-09       Impact factor: 5.782

Review 3.  Biological role of connexin intercellular channels and hemichannels.

Authors:  Rekha Kar; Nidhi Batra; Manuel A Riquelme; Jean X Jiang
Journal:  Arch Biochem Biophys       Date:  2012-03-17       Impact factor: 4.013

4.  Hydrogen-rich water protects against acetaminophen-induced hepatotoxicity in mice.

Authors:  Jing-Yao Zhang; Si-Dong Song; Qing Pang; Rui-Yao Zhang; Yong Wan; Da-Wei Yuan; Qi-Fei Wu; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

5.  Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication.

Authors:  Naomi Hokaiwado; Makoto Asamoto; Mitsuru Futakuchi; Kumiko Ogawa; Satoru Takahashi; Tomoyuki Shirai
Journal:  J Membr Biol       Date:  2007-11-03       Impact factor: 1.843

6.  Hepatic gap junctions in the hepatocarcinogen-resistant DRH rat.

Authors:  Takahiro Gotow; Motoko Shiozaki; Taneaki Higashi; Kentaro Yoshimura; Masahiro Shibata; Eiki Kominami; Yasuo Uchiyama
Journal:  Histochem Cell Biol       Date:  2008-07-17       Impact factor: 4.304

7.  Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis.

Authors:  Taynã Cristina Tiburcio; Joost Willebrords; Tereza Cristina da Silva; Isabel Veloso Alves Pereira; Marina Sayuri Nogueira; Sara Crespo Yanguas; Michaël Maes; Elisangela Dos Anjos Silva; Maria Lucia Zaidan Dagli; Inar Alves de Castro; Cláudia Pinto Oliveira; Mathieu Vinken; Bruno Cogliati
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-02       Impact factor: 2.557

Review 8.  Connexin and pannexin signaling in gastrointestinal and liver disease.

Authors:  Michaël Maes; Sara Crespo Yanguas; Joost Willebrords; Bruno Cogliati; Mathieu Vinken
Journal:  Transl Res       Date:  2015-05-16       Impact factor: 7.012

9.  Connexin32: a mediator of acetaminophen-induced liver injury?

Authors:  Michaël Maes; Mitchell R McGill; Tereza Cristina da Silva; Margitta Lebofsky; Cintia Maria Monteiro de Araújo; Taynã Tiburcio; Isabel Veloso Alves Pereira; Joost Willebrords; Sara Crespo Yanguas; Anwar Farhood; Maria Lucia Zaidan Dagli; Hartmut Jaeschke; Bruno Cogliati; Mathieu Vinken
Journal:  Toxicol Mech Methods       Date:  2016-01-07       Impact factor: 2.987

10.  Connexin32 deficiency exacerbates carbon tetrachloride-induced hepatocellular injury and liver fibrosis in mice.

Authors:  Bruno Cogliati; Sara Crespo Yanguas; Tereza C da Silva; Thiago P A Aloia; Marina S Nogueira; Mirela A Real-Lima; Lucas M Chaible; Daniel S Sanches; Joost Willebrords; Michaël Maes; Isabel V A Pereira; Inar A de Castro; Mathieu Vinken; Maria L Z Dagli
Journal:  Toxicol Mech Methods       Date:  2016-06-07       Impact factor: 2.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.